1. Home
  2. ALLE vs VTRS Comparison

ALLE vs VTRS Comparison

Compare ALLE & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLE
  • VTRS
  • Stock Information
  • Founded
  • ALLE 2013
  • VTRS 1961
  • Country
  • ALLE Ireland
  • VTRS United States
  • Employees
  • ALLE N/A
  • VTRS N/A
  • Industry
  • ALLE Diversified Commercial Services
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • ALLE Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • ALLE Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • ALLE 12.7B
  • VTRS 11.8B
  • IPO Year
  • ALLE N/A
  • VTRS N/A
  • Fundamental
  • Price
  • ALLE $171.86
  • VTRS $10.50
  • Analyst Decision
  • ALLE Hold
  • VTRS Hold
  • Analyst Count
  • ALLE 9
  • VTRS 5
  • Target Price
  • ALLE $163.67
  • VTRS $10.40
  • AVG Volume (30 Days)
  • ALLE 729.6K
  • VTRS 9.1M
  • Earning Date
  • ALLE 10-23-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • ALLE 1.19%
  • VTRS 4.57%
  • EPS Growth
  • ALLE 14.50
  • VTRS N/A
  • EPS
  • ALLE 7.20
  • VTRS N/A
  • Revenue
  • ALLE $3,876,600,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • ALLE $9.25
  • VTRS N/A
  • Revenue Next Year
  • ALLE $5.24
  • VTRS $1.66
  • P/E Ratio
  • ALLE $23.86
  • VTRS N/A
  • Revenue Growth
  • ALLE 5.49
  • VTRS N/A
  • 52 Week Low
  • ALLE $116.57
  • VTRS $6.85
  • 52 Week High
  • ALLE $173.25
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • ALLE 62.41
  • VTRS 61.05
  • Support Level
  • ALLE $166.84
  • VTRS $10.29
  • Resistance Level
  • ALLE $172.95
  • VTRS $10.61
  • Average True Range (ATR)
  • ALLE 2.42
  • VTRS 0.19
  • MACD
  • ALLE -0.55
  • VTRS -0.05
  • Stochastic Oscillator
  • ALLE 78.84
  • VTRS 45.76

About ALLE Allegion plc

Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: